Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?

EDİGER D., Yilmaz D., COŞKUN N. F., Gozu O.

ASTIM ALLERJI IMMUNOLOJI, cilt.8, sa.3, ss.150-156, 2010 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 3
  • Basım Tarihi: 2010
  • Dergi Adı: ASTIM ALLERJI IMMUNOLOJI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.150-156
  • Anahtar Kelimeler: Asthma, allergic rhinitis, immunotherapy, adverse effects
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: Allergen immunotherapy has been proven to be effective and potentially curative therapy in allergic respiratory diseases and in venom allergy. But occurance of adverse systemic reactions due to specific allergen immunotherapy (SIT) remains still major problem. In this study we aimed to assess the adverse reactions of SIT which has been given to patients diagnosed as allergic asthma and/or rhinitis.